Sfoglia per AUTORE
JOHN T
Collezione AOU San Luigi di Orbassano
Items : 2
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.
2024
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...
Expert consensus on perioperative treatment for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527.
2022
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Duan J; Tan F; Bi N; Chen C; Chen KN; Cheng Y; Chu Q; Ge D; Hu J; Huang Y; Jiang T; Long H; Lu Y; Shi M; Wang J; Wang Q; Yang F; Yang N; Yao Y; Ying J; Zhou C; Zhou Q; Zhou Q; Bongiolatti S; Brunelli A; Fiorelli A; Gobbini E; Gridelli C; John T; et alii...